91
High-Dose Melphalan, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma in First Relapse
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:May 11, 2011Completed
Stage III Multiple Myeloma: 437 Clinical Trials, Page 10 of 44
Hide Studies Not Open or Pending
92
Combination Chemotherapy and Interferon Alfa With or Without Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloma
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:December 19, 2013Unknown status
93
Thalidomide, Dexamethasone, and Clarithromycin in Treating Patients With Multiple Myeloma Previously Treated With Transplant
Condition(s):Refractory Multiple Myeloma; Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple MyelomaLast Updated:June 26, 2017Completed
94
Studying Blood Samples From Patients With Multiple Myeloma Who Were Treated With Thalidomide or Lenalidomide
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:May 17, 2017Completed
95
Plerixafor and Filgrastim Following Cyclophosphamide for Stem Cell Mobilization in Patients With Multiple Myeloma
Condition(s):Refractory Multiple Myeloma; Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple MyelomaLast Updated:February 15, 2013Completed
96
Vaccine Therapy in Treating Patients With Multiple Myeloma Who Have Undergone Stem Cell Transplantation
Condition(s):Refractory Multiple Myeloma; Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple MyelomaLast Updated:May 6, 2019Completed
97
Randomized Trial of Cryotherapy Duration Prior to High Dose Melphalan in Myeloma Patients
Condition(s):Refractory Multiple Myeloma; Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple MyelomaLast Updated:June 27, 2017Completed
98
Open-label Study, to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Bone Lesions Secondary to Multiple Myeloma.
Condition(s):Multiple MyelomaLast Updated:April 14, 2015Withdrawn
99
Lenalidomide and Dexamethasone With or Without Thalidomide in Treating Patients With Multiple Myeloma
Condition(s):DS Stage I Plasma Cell Myeloma; DS Stage II Plasma Cell Myeloma; DS Stage III Plasma Cell MyelomaLast Updated:December 12, 2022Active, not recruiting
100
High-Dose Melphalan and a Second Stem Cell Transplant or Low-Dose Cyclophosphamide in Treating Patients With Relapsed Multiple Myeloma After Chemotherapy
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:August 12, 2013Unknown status